Journal of Adolescent Health
Volume 40, Issue 4 , Pages 358.e1-358.e8 , April 2007

Health Risk Behaviors among HIV-Infected Youth in Bangkok, Thailand

  • Chokechai Rongkavilit, M.D.

      Affiliations

    • The Carman and Ann Adams Department of Pediatrics and Children’s Hospital of Michigan, Wayne State University School of Medicine, Detroit, Michigan
    • Corresponding Author InformationAddress correspondence to: Dr. Chokechai Rongkavilit, Division of Pediatric Infectious Diseases, 3901 Beaubien Blvd., Detroit, MI 48201.
    • ,
  • Sylvie Naar-King, Ph.D.

      Affiliations

    • The Carman and Ann Adams Department of Pediatrics and Children’s Hospital of Michigan, Wayne State University School of Medicine, Detroit, Michigan
    • ,
  • Theshinee Chuenyam, R.N.

      Affiliations

    • HIV Netherlands-Australia-Thailand Research Collaboration (HIV-NAT) and Thai Red Cross AIDS Research Center, Bangkok, Thailand
    • ,
  • Bo Wang, Ph.D.

      Affiliations

    • The Carman and Ann Adams Department of Pediatrics and Children’s Hospital of Michigan, Wayne State University School of Medicine, Detroit, Michigan
    • ,
  • Kathryn Wright, D.O.

      Affiliations

    • The Carman and Ann Adams Department of Pediatrics and Children’s Hospital of Michigan, Wayne State University School of Medicine, Detroit, Michigan
    • ,
  • Praphan Phanuphak, M.D., Ph.D.

      Affiliations

    • HIV Netherlands-Australia-Thailand Research Collaboration (HIV-NAT) and Thai Red Cross AIDS Research Center, Bangkok, Thailand

Received 24 May 2006 ,Accepted 3 November 2006.

References 

  1. UNIADS/WHO. AIDS epidemic update. 2005;December
  2. Thai Working Group on HIV/AIDS.. Situations of AIDS in Thailand. Thailand: Ministry of Public Health; 2006;
  3. Ruxrungtham K, Brown T, Phanuphak P. HIV/AIDS in Asia. Lancet. 2004;364:69–82
  4. Murphy DA, Belzer M, Durako SJ, Sarr M, Wilson CM, Muenz LR. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus. Arch Pediatr Adolesc Med. 2005;159:764–770
  5. Diamond C, Richardson JL, Milam J, et al. Use of and adherence to antiretroviral therapy is associated with decreased sexual risk behavior in HIV clinic patients. J Acquir Immune Defic Syndr. 2005;39:211–218
  6. Kalichman SC, Rompa D. HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy. Sex Transm Infect. 2003;79:59–61
  7. Aloisi MS, Arici C, Balzano R, et al. Behavioral correlates of adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31(suppl 3):S145–S148
  8. Belzer ME, Fuchs DN, Luftman GS, Tucker DJ. Antiretroviral adherence issues among HIV-positive adolescents and young adults. J Adolesc Health. 1999;25:316–319
  9. Martinez J, Bell D, Camacho R, et al. Adherence to antiviral drug regimens in HIV-infected adolescent patients engaged in care in a comprehensive adolescent and young adult clinic. J Natl Med Assoc. 2000;92:55–61
  10. Murphy DA, Wilson CM, Durako SJ, Muenz LR, Belzer M. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care. 2001;13:27–40
  11. Lynch DA, Krantz S, Russell JM, Hornberger LL, Van Ness CJ. HIV infection: a retrospective analysis of adolescent high-risk behaviors. J Pediatr Health Care. 2000;14:20–25
  12. Hein K, Dell R, Futterman D, Rotheram-Borus MJ, Shaffer N. Comparison of HIV+ and HIV− adolescents: risk factors and psychosocial determinants. Pediatrics. 1995;95:96–104
  13. Holland CA, Ma Y, Moscicki B, Durako SJ, Levin L, Wilson CM. Seroprevalence and risk factors of hepatitis B, hepatitis C, and human cytomegalovirus among HIV-infected and high-risk uninfected adolescents: findings of the REACH Study (Adolescent Medicine HIV/AIDS Research Network). Sex Transm Dis. 2000;27:296–303
  14. Vermund SH, Wilson CM, Rogers AS, Partlow C, Moscicki AB. Sexually transmitted infections among HIV infected and HIV uninfected high-risk youth in the REACH study (Reaching for Excellence in Adolescent Care and Health). J Adolesc Health. 2001;29:49–56
  15. Mott FL, Haurin RJ. Linkages between sexual activity and alcohol and drug use among American adolescents. Fam Plann Perspect. 1988;20:128–136
  16. Walter HJ, Vaughan RD, Ragin DF, Cohall AT, Kasen S, Fullilove RE. Prevalence and correlates of AIDS-risk behaviors among urban minority high school students. Prev Med. 1993;22:813–824
  17. Chesney M, Ickovics J, Chambers D, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments (Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG)). AIDS Care. 2000;12:255–266
  18. Moatti JP, Carrieri MP, Spire B, Gastaut JA, Cassuto JP, Moreau J. Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment (The Manif 2000 study group). AIDS. 2000;14:151–155
  19. Lucas GM, Gebo KA, Chaisson RE, Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS. 2002;16:767–774
  20. Frey MA, Denyes MJ. Health and illness self-care in adolescents with IDDM: a test of Orem’s theory. ANS Adv Nurs Sci. 1989;12:67–75
  21. Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin. 2004;5:74–79
  22. Naar-King S, Templin T, Wright K, et al. Psychosocial factors and medication adherence in HIV+ youth. AIDS Patient Care STDS. 2006;20:44–47
  23. Naar-King S, Frey M, Harris M, Arfken C. Measuring adherence to treatment of paediatric HIV/AIDS. AIDS Care. 2005;17:345–349
  24. Carney MA, Tennen H, Affleck G, Del Boca FK, Kranzler HR. Levels and patterns of alcohol consumption using timeline follow-back, daily diaries and real-time “electronic interviews.”. J Stud Alcohol. 1998;59:447–454
  25. Fals-Stewart W, O’Farrell TJ, Freitas TT, McFarlin SK, Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol. 2000;68:134–144
  26. Naar-King S, Wright K, Parsons JT, Frey M, Templin T, Ondersma S. Transtheoretical model and substance use in HIV+ youth. AIDS Care. 2006;18:839–845
  27. Naar-King S, Wright K, Parsons JT, et al. Healthy choices: motivational enhancement therapy for health risk behaviors in HIV+ youth. AIDS Educ Prev. 2006;18:1–11
  28. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30
  29. Flynn PM, Rudy BJ, Douglas SD, et al. Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy. J Infect Dis. 2004;190:271–279
  30. Nemes MI, Carvalho HB, Souza MF. Antiretroviral therapy adherence in Brazil. AIDS. 2004;18(Suppl 3):S15–S20
  31. Laurent C, Diakhate N, Gueye NF, et al. The Senegalese government’s highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS. 2002;16:1363–1370
  32. Laurent C, Ngom Gueye NF, Ndour CT, et al. Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults. J Acquir Immune Defic Syndr. 2005;38:14–17
  33. Oyugi JH, Byakika-Tusiime J, Charlebois ED, et al. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr. 2004;36:1100–1102
  34. Akileswaran C, Lurie MN, Flanigan TP, Mayer KH. Lessons learned from use of highly active antiretroviral therapy in Africa. Clin Infect Dis. 2005;41:376–385
  35. Muangchana K, Prommoon W, Somton P. Antiretroviral drug taking behaviors of HIV/AIDS out-patients of Bamrasnaradura infectious disease insitute, Thailand, 2003 [WePeB5810]. In: XV International AIDS Conference. Bangkok, Thailand, 2004.
  36. Beyrer C, Eiumtrakul S, Celentano DD, Nelson KE, Ruckphaopunt S, Khamboonruang C. Same-sex behavior, sexually transmitted diseases and HIV risks among young northern Thai men. AIDS. 1995;9:171–176
  37. London AS, VanLandingham MJ, Grandjean N. Socio-demographic correlates, HIV/AIDS-related cofactors, and measures of same-sex sexual behaviour among northern Thai male soldiers. Health Transit Rev. 1997;7:33–60
  38. van Griensven F, Thanprasertsuk S, Jommaroeng R, et al. Evidence of a previously undocumented epidemic of HIV infection among men who have sex with men in Bangkok, Thailand. AIDS. 2005;19:521–526
  39. van Griensven F, Supawitkul S, Kilmarx PH, et al. Rapid assessment of sexual behavior, drug use, human immunodeficiency virus, and sexually transmitted diseases in northern Thai youth using audio-computer-assisted self-interviewing and noninvasive specimen collection. Pediatrics. 2001;108:E13
  40. UNIADS/WHO. Thailand: Epidemiological Fact Sheets on HIV/AIDS and Sexually Transmitted Infections Update. 2004;December
  41. van Griensven F, Varangrat A, Naorat S, et al. HIV surveillance among men who have sex with men populations in Thailand: evidence for high prevalence and incidence (abstract 919). Conference on Retroviruses and Opportunistic Infections. 2006;Denver, CO
  42. Ruangkanchanasetr S, Plitponkarnpim A, Hetrakul P, Kongsakon R. Youth risk behavior survey: Bangkok, Thailand. J Adolesc Health. 2005;36:227–235

PII: S1054-139X(06)00436-8

doi: 10.1016/j.jadohealth.2006.11.004

Journal of Adolescent Health
Volume 40, Issue 4 , Pages 358.e1-358.e8 , April 2007

Article Tools